Mesothelioma is an aggressive cancer primarily caused by asbestos exposure. While there is no cure for this cancer, early detection and treatment can help manage the disease. Many often wonder if mesothelioma can be detected in its early stages, which can help control it before it becomes aggressive. Detecting mesothelioma has been challenging. However, ongoing research offers hope for improving early detection rates of this disease. Notably, recent advancements in detection, including a breakthrough discovery by the Mayo Clinic in 2024, offer hope. For instance, the Mayo Clinic researchers have developed an innovative blood test that significantly improves early detection rates, marking this a significant step forward in diagnosing this devastating disease.
How is Mesothelioma Detected?
Mesothelioma is not easily detectable because no single test can confirm its presence. Doctors often rely on a combination of tests, such as imaging scans, blood tests, and lung function assessments, to identify the potential for mesothelioma. Mesothelioma can take up to 60 years to manifest fully, making imaging tests like X-rays, CT scans, and MRIs, which check for abnormalities in the lungs or abdomen, inconclusive in fully establishing mesothelioma and distinguishing it from other illnesses. Blood tests, on the other hand, check for specific proteins and genetic markers linked to mesothelioma, such as fibulin-3 and soluble mesothelin-related peptides (SMRPs). Although these tests provide helpful indicators, they are not definitive enough for diagnosis.